Insmed Inc [NASDAQ: INSM] plunged by $3109895.15 during the normal trading session on Thursday and reaching a high of $105.8 during the day while it closed the day at $3110000.0.
Insmed Inc stock has also gained 2.29% of its value over the past 7 days. However, INSM stock has inclined by 32.87% in the 3 months of the year. Over the past six months meanwhile, it has gained 44.43% and gained 48.68% year-on date.
The market cap for INSM stock reached $19.33 billion, with 189.95 million shares outstanding and 185.71 million shares in the current float. Compared to the average trading volume of 3.11M shares, INSM reached a trading volume of 3948891 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Insmed Inc [INSM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for INSM shares is $112.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on INSM stock is a recommendation set at 1.05. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Jefferies have made an estimate for Insmed Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 13, 2025. While these analysts kept the previous recommendation, RBC Capital Mkts raised their target price to Outperform. The new note on the price target was released on February 25, 2025, representing the official price target for Insmed Inc stock. Previously, the target price had yet another raise to $48, while Truist analysts kept a Buy rating on INSM stock.
The Price to Book ratio for the last quarter was 186.63, with the Price to Cash per share for the same quarter was set at 6.31.
INSM stock trade performance evaluation
Insmed Inc [INSM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.29. With this latest performance, INSM shares gained by 49.57% in over the last four-week period, additionally plugging by 44.43% over the last 6 months – not to mention a rise of 47.36% in the past year of trading.
Insmed Inc [INSM]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Insmed Inc [INSM] shares currently have an operating margin of -225.44% and a Gross Margin at 75.17%. Insmed Inc’s Net Margin is presently recorded at -265.93%.
Return on Equity for this stock declined to -68.42%, with Return on Assets sitting at -68.42%.
Earnings per share (EPS) analysis for Insmed Inc [INSM] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for INSM. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Insmed Inc go to 47.55%.
Insmed Inc [INSM]: Institutional Ownership
There are presently around $111.04%, or 111.90% of INSM stock, in the hands of institutional investors. The top three institutional holders of INSM stocks are: VANGUARD GROUP INC with ownership of 16.01 million shares, which is approximately 10.3509%. BLACKROCK INC., holding 14.26 million shares of the stock with an approximate value of $$955.72 million in INSM stocks shares; and BLACKROCK INC., currently with $$814.95 million in INSM stock with ownership which is approximately 7.8625%.
